The protective effect of astragaloside IV against benzo[a]pyrene induced endothelial progenitor cell dysfunction
Authors:
- 1 July 2015
- journal article
- Published by Elsevier in Life Sciences
- Vol. 132, 13-19
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Province Natural Science Foundation (Y2110550, LY13H310006, Y13H020019)
This publication has 52 references indexed in Scilit:
- Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathwaysApoptosis, 2013
- Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4Protoplasma, 2012
- Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In VivoPLOS ONE, 2012
- Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cellsCardiovascular Diabetology, 2012
- Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1α Accumulation via Phosphatidylinositol 3-Kinase/Akt PathwayThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Essential Role of Copper-Zinc Superoxide Dismutase for Ischemia-Induced Neovascularization Via Modulation of Bone Marrow–Derived Endothelial Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Potential use of endothelial progenitor cells for regeneration of the vasculatureTherapeutic Advances in Cardiovascular Disease, 2009
- Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitusCardiovascular Diabetology, 2009
- RAGE signaling sustains inflammation and promotes tumor developmentJournal of Experimental Medicine, 2008
- An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk MarkersArchives of internal medicine (1960), 2006